Publication: Plasmodium falciparum Plasmepsin v (PfPMV): Insights into recombinant expression, substrate specificity and active site structure
Issued Date
2015-05-29
Resource Type
ISSN
18729428
01666851
01666851
Other identifier(s)
2-s2.0-84930667506
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Molecular and Biochemical Parasitology. Vol.201, No.1 (2015), 5-15
Suggested Citation
Nonlawat Boonyalai, Pichamon Sittikul, Jirundon Yuvaniyama Plasmodium falciparum Plasmepsin v (PfPMV): Insights into recombinant expression, substrate specificity and active site structure. Molecular and Biochemical Parasitology. Vol.201, No.1 (2015), 5-15. doi:10.1016/j.molbiopara.2015.05.004 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/35453
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Plasmodium falciparum Plasmepsin v (PfPMV): Insights into recombinant expression, substrate specificity and active site structure
Other Contributor(s)
Abstract
© 2015 Elsevier B.V. All rights reserved. Plasmepsin V from Plasmodium falciparum (PfPMV) is responsible for the cleavage of the Plasmodium export element (PEXEL) motif at the N-terminus of several hundreds of the exported proteins. PfPMV is necessary for parasite viability and has become a novel promising target for antimalarial therapy. The first recombinant expression of soluble, active PfPMV as thioredoxin fusion proteins is reported herein. Two truncated forms of PfPMV were fused to thioredoxin (Trx) to generate Trx-PfPMVp37 and Trx-PfPMVm84. The fusion proteins were successfully purified using Ni<sup>2+</sup> affinity chromatography in combination with ATP treatment to eliminate Escherichia coli HSP60 contaminant. Trx-PfPMVm84 could hydrolyze the PEXEL-containing peptides more efficiently than Trx-PfPMVp37. Interestingly, both Trx-PfPMVs preferred to cleave PfEMP2 peptide over HRPII peptide. The replacement of Ser with Val or Glu at P<inf>1</inf>′ position created a substrate with 75% reduction in the enzyme activity, whereas the substitution of Ile with Lys or Glu at P<inf>2</inf> position reduced the cleavage efficiency by 30%. The activity of Trx-PfPMVm84 was inhibited by PMSF and nelfinavir but not by pepstatin A. After the removal of Trx domain, activities of both enzymes toward PfEMP2 and HRPII peptides were fitted to the Michaelis-Menten model to determine kinetic parameters. The K<inf>m</inf> values toward both peptides were apparently much lower than the previously reported data although with similar k<inf>cat</inf> values. Along with an improved PfPMV preparation protocol, these findings have provided insights into its substrate specificity at P<inf>2</inf> and P<inf>1</inf>′ positions as well as interactions among the enzyme, substrates, and inhibitors.
